Stay updated on SAGE-217 for Severe Depression Clinical Trial

Sign up to get notified when there's something new on the SAGE-217 for Severe Depression Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SAGE-217 for Severe Depression Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page has changed from a 403 error screen to the full record for a Phase 2 study of SAGE-217 for major depressive disorder, including study design, eligibility, outcomes, publications, and study documents.
    Difference
    100%
    Check dated 2026-11-08T23:12:55.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T23:18:25.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a transition in terminology, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-25T22:35:15.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov 403 error page. The displayed error content and layout remain unchanged.
    Difference
    0.2%
    Check dated 2026-10-18T22:49:21.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T23:09:52.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, blocking access to the record. The page displays the standard header and footer while the main content area shows the access-denied message.
    Difference
    0.5%
    Check dated 2026-09-27T22:45:00.000Z thumbnail image

Stay in the know with updates to SAGE-217 for Severe Depression Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SAGE-217 for Severe Depression Clinical Trial page.